These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 31042384

  • 21. Neurofilament Immunohistochemistry Followed by Luxol Fast Blue, for Staining Axons and Myelin in the Same Paraffin Section of Spinal Cord.
    Moszczynski AJ, Volkening K, Strong MJ.
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):562-565. PubMed ID: 31652146
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M, Yamasaki T, Yui J, Hatori A, Xie L, Kawamura K, Asagawa C, Kumata K, Yoshida Y, Ogawa M, Nengaki N, Fukumura T, Zhang MR.
    J Med Chem; 2012 Mar 08; 55(5):2342-52. PubMed ID: 22316010
    [Abstract] [Full Text] [Related]

  • 23. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M.
    J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845
    [Abstract] [Full Text] [Related]

  • 24. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, Mantzilas D, Oulie I, Rogstad A, Trigg W, Jones PA.
    Nucl Med Biol; 2015 Sep 07; 42(9):711-9. PubMed ID: 26072270
    [Abstract] [Full Text] [Related]

  • 25. [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis.
    Hoehne A, James ML, Alam IS, Ronald JA, Schneider B, D'Souza A, Witney TH, Andrews LE, Cropper HC, Behera D, Gowrishankar G, Ding Z, Wyss-Coray T, Chin FT, Biswal S, Gambhir SS.
    J Neuroinflammation; 2018 Feb 22; 15(1):55. PubMed ID: 29471880
    [Abstract] [Full Text] [Related]

  • 26. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand.
    Zhang L, Villalobos A, Beck EM, Bocan T, Chappie TA, Chen L, Grimwood S, Heck SD, Helal CJ, Hou X, Humphrey JM, Lu J, Skaddan MB, McCarthy TJ, Verhoest PR, Wager TT, Zasadny K.
    J Med Chem; 2013 Jun 13; 56(11):4568-79. PubMed ID: 23651455
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.
    Wang C, Wu C, Zhu J, Miller RH, Wang Y.
    J Med Chem; 2011 Apr 14; 54(7):2331-40. PubMed ID: 21391687
    [Abstract] [Full Text] [Related]

  • 28. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
    Yanamoto K, Kumata K, Yamasaki T, Odawara C, Kawamura K, Yui J, Hatori A, Suzuki K, Zhang MR.
    Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1707-10. PubMed ID: 19217778
    [Abstract] [Full Text] [Related]

  • 29. Cellular responses in the spinal cord during development of hypomyelination in the mv rat.
    Izawa T, Takenaka S, Ihara H, Kotani T, Yamate J, Franklin RJ, Kuwamura M.
    Brain Res; 2008 Feb 21; 1195():120-9. PubMed ID: 18206135
    [Abstract] [Full Text] [Related]

  • 30. Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging.
    Andrés JI, De Angelis M, Alcázar J, Iturrino L, Langlois X, Dedeurwaerdere S, Lenaerts I, Vanhoof G, Celen S, Bormans G.
    J Med Chem; 2011 Aug 25; 54(16):5820-35. PubMed ID: 21777010
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with (18)F-incorporated oligodeoxynucleotides.
    Mukai H, Ozaki D, Cui Y, Kuboyama T, Yamato-Nagata H, Onoe K, Takahashi M, Wada Y, Imanishi T, Kodama T, Obika S, Suzuki M, Doi H, Watanabe Y.
    J Control Release; 2014 Apr 28; 180():92-9. PubMed ID: 24566256
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
    Matthews PM, Datta G.
    Expert Opin Drug Discov; 2015 May 28; 10(5):557-70. PubMed ID: 25843125
    [Abstract] [Full Text] [Related]

  • 37. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y, Nomura T, Bochimoto H, Murakami K, Tanaka T, Watanabe T, Yoshida S.
    Neurochem Int; 2015 Feb 28; 81():16-27. PubMed ID: 25595039
    [Abstract] [Full Text] [Related]

  • 38. Imaging B Cells in a Mouse Model of Multiple Sclerosis Using 64Cu-Rituximab PET.
    James ML, Hoehne A, Mayer AT, Lechtenberg K, Moreno M, Gowrishankar G, Ilovich O, Natarajan A, Johnson EM, Nguyen J, Quach L, Han M, Buckwalter M, Chandra S, Gambhir SS.
    J Nucl Med; 2017 Nov 28; 58(11):1845-1851. PubMed ID: 28687602
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An [18F]-Positron-Emitting, Fluorescent, Cerebrospinal Fluid Probe for Imaging Damage to the Brain and Spine.
    Kommidi H, Guo H, Chen N, Kim D, He B, Wu AP, Aras O, Ting R.
    Theranostics; 2017 Nov 28; 7(9):2377-2391. PubMed ID: 28744321
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.